Why Elon Musk's Grok-2 AI images is raising serious concerns Another Covid wave? Omicron variant FLiRT spreading like wildfire in the U.S., is it life-threatening? Bengaluru couple moves to one of ...
The side effects of newly discovered COVID strain XEC might not be more severe, but appears to be more contagious, ...
Omicron variant KP.3.1.1, also known as deFLuQE, made up over half (52.7%) of COVID-19 cases between Sept. 1 and Sept. 14. However, XEC and a variant known as MV.1 seem poised to become the next ...
A new COVID variant is spreading rapidly and could soon become the dominant variant around the globe. The variant, called XEC, was first detected in Germany in August and appears to have a growth ...
Researchers are tracking the latest COVID strain "spreading rapidly" in parts of Europe. Here's what we know about variant ...
What are the new XEC COVID variant symptoms, and when will it hit the U.S.? Doctors explain what to watch for, and the best ...
A new COVID variant known as the "XEC variant" is raising questions and capturing the attention of researchers heading into the fall and winter season. The variant has been largely spreading overseas ...
Q I had a COVID-19 vaccine in June 2023, so I’m overdue for another. I’ve heard there’s going to be an updated vaccine coming ...
A new Covid variant is spreading rapidly and has caught the attention of the research world: 111 samples have already been reported from 15 countries, across three different continents.
The U.S. Food and Drug Administration recently green-lit new 2024-25 COVID-19 vaccinations ahead of the fall and winter seasons, when respiratory viruses spread more rapidly within communities.
New COVID vaccines should be available for the ... from Pfizer and Moderna for people 6 months and older. The newest variant, KP.3.1.1, is the predominant and only major variant increasing in ...
According to the FDA press release, the updated COVID-19 vaccines include “a monovalent (single) component that corresponds to the Omicron variant KP.2 strain of SARS-CoV-2.” In a statement ...